{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:58:20Z","timestamp":1793361500382,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtha.2026.05.016","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:17:34Z","timestamp":1779376654000},"page":"2726-2731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A light in the dark\u2014reframing direct oral anticoagulant pharmacokinetics and pharmacodynamics for near-patient decision-making"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2405-7912","authenticated-orcid":false,"given":"Joseph R.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1237-9797","authenticated-orcid":false,"given":"Jack","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.05.016_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/a-2464-2887","article-title":"Multidisciplinary expert guidance for the management of severe bleeding on oral anticoagulation: an algorithm for practicing clinicians","volume":"125","author":"Mithoowani","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib2","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jtha.2024.07.009","article-title":"Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH","volume":"22","author":"Levy","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"1 Suppl","key":"10.1016\/j.jtha.2026.05.016_bib3","doi-asserted-by":"crossref","first-page":"22S","DOI":"10.1378\/chest.119.1_suppl.22S","article-title":"Managing oral anticoagulant therapy","volume":"119","author":"Ansell","year":"2001","journal-title":"Chest"},{"issue":"6 Suppl","key":"10.1016\/j.jtha.2026.05.016_bib4","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.05.016_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.thromres.2015.12.001","article-title":"Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: results observed in four anticoagulation clinics","volume":"137","author":"Testa","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.05.016_bib6","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1111\/jth.15901","article-title":"Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure","volume":"20","author":"Shaw","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.05.016_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jama.2015.59","article-title":"Are new oral anticoagulant dosing recommendations optimal for all patients?","volume":"313","author":"Powell","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.05.016_bib9","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1111\/jth.15104","article-title":"The relationship between DOAC levels and clinical outcomes: The measures tell the tale","volume":"18","author":"Toorop","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/a-1981-1763","article-title":"Assessment of DOAC in GEriatrics (Adage Study): rivaroxaban\/apixaban concentrations and thrombin generation profiles in NVAF very elderly patients","volume":"123","author":"Foulon-Pinto","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jth.15563","article-title":"Inter- and intra-individual concentrations of direct oral anticoagulants: the KIDOAC study","volume":"20","author":"Toorop","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib12","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.jtha.2025.06.031","article-title":"Plasma levels measurement of the four direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events","volume":"23","author":"Godino","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib13","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1016\/j.jtha.2025.08.003","article-title":"Direct oral anticoagulant (DOAC) levels, bleeding, and breakthrough thrombosis: fog of war","volume":"23","author":"Shaw","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","article-title":"The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)","volume":"63","author":"Reilly","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2026.05.016_bib15","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/S0140-6736(14)61943-7","article-title":"Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial","volume":"385","author":"Ruff","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.05.016_bib16","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1055\/a-2521-0923","article-title":"Influence of direct oral anticoagulant levels and thrombin generation on postoperative bleeding [SONAR]: a nested case-control study","volume":"125","author":"Shaw","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib17","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1182\/bloodadvances.2023012408","article-title":"Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study","volume":"8","author":"Testa","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.016_bib18","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1182\/bloodadvances.2024013126","article-title":"More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study","volume":"8","author":"Palareti","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.016_bib19","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1055\/s-0038-1649507","article-title":"Mechanistic basis for the differential effects of rivaroxaban and apixaban on global tests of coagulation","volume":"2","author":"Kim","year":"2018","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2026.05.016_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtha.2022.11.029","article-title":"DOAC-associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature","volume":"21","author":"Shaw","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2005.05612.x","article-title":"The measurement and application of thrombin generation","volume":"130","author":"Baglin","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.016_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2026.100135","article-title":"Thrombin generation and the pharmacodynamics of parenteral anticoagulants","volume":"78","author":"Shaw","year":"2026","journal-title":"Pharm Rev"},{"key":"10.1016\/j.jtha.2026.05.016_bib23","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1111\/ijlh.13356","article-title":"Are the DOAC plasma level thresholds appropriate for clinical decision-making? A reappraisal using thrombin generation testing","volume":"43","author":"Evrard","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.05.016_bib24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/ijlh.13618","article-title":"Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants","volume":"43","author":"Metze","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.05.016_bib25","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jth.15287","article-title":"Recommendations for the measurement of thrombin generation: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"19","author":"Ninivaggi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib26","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.121.057844","article-title":"Final study report of andexanet alfa for major bleeding with factor Xa inhibitors","volume":"147","author":"Milling","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.05.016_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5853\/jos.2017.00395","article-title":"Intravenous thrombolysis in patients with stroke taking rivaroxaban using drug specific plasma levels: experience with a standard operation procedure in clinical practice","volume":"19","author":"Seiffge","year":"2017","journal-title":"J Stroke"},{"key":"10.1016\/j.jtha.2026.05.016_bib28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.acvd.2013.04.009","article-title":"Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013","volume":"106","author":"Pernod","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jtha.2026.05.016_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0039-1700545","article-title":"Accuracy of a rapid diagnostic test for the presence of direct oral factor Xa or thrombin inhibitors in urine-A multicenter trial","volume":"120","author":"Harenberg","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib30","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1161\/STROKEAHA.122.041555","article-title":"Assessment of direct oral anticoagulant status using the DOASENSE dipstick in thrombolysis eligible patients with stroke: proof-of-concept study","volume":"54","author":"Tan","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2026.05.016_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.991675","article-title":"The impact of direct oral anticoagulants on viscoelastic testing - a systematic review","volume":"9","author":"Sahli","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2026.05.016_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/ijlh.12744","article-title":"Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM)","volume":"40","author":"Seyve","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.05.016_bib33","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jtha.2025.11.003","article-title":"A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant-associated bleeding","volume":"24","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.016_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11239-022-02739-w","article-title":"Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review","volume":"55","author":"Siegal","year":"2023","journal-title":"J Thromb Thrombolysis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:21:49Z","timestamp":1785885709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626003399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1538783626003399"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.016","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A light in the dark\u2014reframing direct oral anticoagulant pharmacokinetics and pharmacodynamics for near-patient decision-making","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}